GlassScriptPhysician profile
Thomas J Welch
NPI 1689017329
$9,537.99
in general payments reported to CMS, 2019-2025
26 companies · $1,242 in 2025
The $1,242 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,998 · 2021: $1,327 · 2022: $1,762 · 2023: $1,234 · 2024: $1,976 · 2025: $1,242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,451.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,216.41 | 2020-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abiomed | $2,171.39 | 2021-2025 | Impella |
| Medtronic Vascular, INC. | $1,801.32 | 2020 | |
| Inari Medical, INC. | $1,014.76 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $325.35 | 2021-2025 | Corevalve Evolut R |
| Amgen INC. | $272.52 | 2022-2025 | Repatha, Repatha |
| Pfizer INC. | $271.47 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $230.77 | 2020-2025 | Lifevest |
| Boston Scientific Corporation | $208.16 | 2023-2024 | Watchman Access System, Watchman Flx |
| Philips North America LLC | $185.92 | 2022-2024 | (Bh4) Igt Devices Undivided |
| Astrazeneca Pharmaceuticals LP | $142.16 | 2021-2022 | |
| Penumbra, INC. | $109.06 | 2021 | |
| Shockwave Medical, INC | $103.48 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $96.20 | 2023-2024 | |
| Lexicon Pharmaceuticals, INC. | $89.42 | 2023-2024 | Inpefa |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $62.53 | 2023-2024 | Alphavac |
| Acist Medical Systems, INC. | $36.00 | 2020 | |
| Stryker Corporation | $32.66 | 2025 | Clottriever Bold Catheter |
| Abbott Laboratories | $30.87 | 2023 | Diamondback Coronary |
| Merck Sharp & Dohme LLC | $24.68 | 2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.13 | 2023 | Jardiance |
| Cardiovascular Systems INC. | $22.64 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $19.57 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $16.62 | 2025 | |
| Bridgebio Pharma, INC. | $15.02 | 2025 | Attruby |
| Kestra Medical Technology Services, INC. | $14.88 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Welch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.